ArticleEye (London, England)2019

Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications.

Abdul Mannan BaigPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.